会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • ANTI-CANCER COMPOSITION COMPOSED OF ANTI-CANCER AND ANTI-MALARIAL DRUGS
    • 抗癌组合物和抗疟药物组成的抗癌组合物
    • WO2002013826A1
    • 2002-02-21
    • PCT/KR2001/001314
    • 2001-08-02
    • KEUM, Ki-ChangYOO, Nae-ChoonYOO, Won-Min
    • KEUM, Ki-ChangYOO, Nae-ChoonYOO, Won-Min
    • A61K31/47
    • A61K31/47A61K31/704A61K33/24A61K2300/00
    • The present invention relates to complex compositions of anticancer drugs, which are administrated in combination with antimalarial drugs for reducing a minimum IC 50 of anticancer drugs and inhibiting development of drug resistance of cancer cells caused by anticancer drugs, thereby enhancing the effect of the anticancer drugs. More particularly, the present invention relates to complex compositions of anticancer drugs, which are administrated in combination with antimalarial drugs for a minimun IC 50 of anticancer drugs and inhibiting development of drug resistance of cancer cells caused by anticancer drugs, thereby enhancing the effect of the anticancer drugs; in which the anticancer drugs are selected from the group consisting of doxorubicin, cisplatin, and the like and the antimalarial drugs are selected from the group consisting of hydroxchloroquine, chloroquine, primaquine and the like.
    • 本发明涉及抗癌药物的复合组合物,其与抗疟药物组合施用以降低抗癌药物的最低IC50并抑制由抗癌药物引起的癌细胞耐药性的发展,从而增强抗癌药物的作用。 更具体地说,本发明涉及抗癌药物的复合组合物,其与抗疟药联合施用,用于抗癌药物的最小IC50,抑制由抗癌药物引起的癌细胞耐药性的发展,从而增强抗癌作用 药物; 其中抗癌药物选自多柔比星,顺铂等,抗疟药选自羟氯喹,氯喹,普氨氨酸等。